Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide.
View Top Employees from Samsung BiologicsWebsite | https://www.samsungbiologics.com |
Revenue | $571 million |
Employees | 2,500 (1,103 on RocketReach) |
Founded | 2011 |
Phone | +82 32-455-3114 |
Fax | +82 32-455-3825 |
Technologies |
JavaScript,
HTML,
Twitter
+32 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Biotechnology, Business Services, Science and Engineering |
Web Rank | 2 Million |
Keywords | Contract Development And Manufacturing, Biologics, Biopharmaceuticals, Pharmaceutical Manufacturing |
Competitors | Catalent Pharma Solutions, FUJIFILM Diosynth Biotechnologies, KBI Biopharma, Patheon Inc, Rentschler Biopharma SE |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Samsung Biologics employee's phone or email?
The Samsung Biologics annual revenue was $571 million in 2024.
Tae Kim is the President and Chair of BOD of Samsung Biologics.
1,103 people are employed at Samsung Biologics.
The NAICS codes for Samsung Biologics are [54171, 5417, 541713, 541, 54].
The SIC codes for Samsung Biologics are [873, 87].